Brightlands Venture Partners

Grassa BV specializes in the valorization of plant-based streams through bioraffinage. Based in the Netherlands, Grassa converts grass and vegetable waste into high-quality, protein-rich animal feed and other valuable products using its mobile bio-refinery technology. This process generates four main outputs: fibers, protein, phosphate, and 'wei' (sap). By transforming locally available green residual flows such as grass from meadows, agricultural waste, water plants, or nature grass, Grassa supports sustainable agriculture and helps farmers enhance their income while addressing food scarcity.

Founded in 2015, PL BioScience specializes in manufacturing high-quality cell culture products based on human platelet lysate for stem cell research. Its portfolio includes research-grade, GMP-grade, and customized products, along with support services. The company's offerings cater to various applications, from basic research to clinical applications.

Vivalyx operates a patented organ preservation system designed to enhance the success of organ transplantation. Its technology combines static cold storage with machine perfusion, offering a blood-free alternative that aims to increase the vitality and availability of donor organs, thereby improving patient outcomes.

Qorium is a biotechnology company that employs cell culturing and tissue engineering technologies to produce premium, real leather. Its sustainable, collagen-based leather aims to minimize environmental impact by being independent of the meat industry and deforestation.

Matisse Pharmaceuticals B.V. is a biotechnology company based in Geleen, the Netherlands, specializing in the development of pharmaceutical therapies aimed at treating sepsis and related disorders associated with fulminant inflammation. Founded in 2014, the company is focused on creating innovative treatments to neutralize cytotoxic components of the inflammatory system. Its lead product, M6229, is currently in the pre-clinical phase and targets severe sepsis and septic shock, aiming to provide healthcare professionals with advanced therapeutic options to improve patient outcomes in critical conditions.

Corporis Medical develops and commercializes diagnostic tools for minimally invasive surgery, focusing on laparoscopic and bowel procedures. Its devices help surgeons predict anastomosis quality during operations, reducing postoperative complications such as anastomotic leakages. By improving diagnostic accuracy and surgical outcomes, the company lowers healthcare costs and enhances access to effective surgical care.

ReSolved Technologies specializes in recycling engineering plastics and polyvinyl chloride from complex waste streams. Utilizing a unique solvent-based technology, the company extracts and converts these plastics into high-purity recycled material, equivalent to virgin quality. This recycled product is suitable for use in high-end markets, facilitating closed-loop recycling and enabling businesses to enhance their sustainability performance by reducing their carbon footprint and increasing product circularity.

Circularise is a provider of digital product passports and mass balance bookkeeping software, focusing on sustainability and supply chain transparency. The company’s software aids suppliers, manufacturers, recyclers, and brands across various industries, including chemicals, plastics, and metals, in tracing materials and sharing their environmental footprint securely. Its primary offering, the digital product passport, compiles detailed records of a product's origin, material composition, and environmental data, supported by a blockchain-powered chain of custody for data security. Circularise's platform enables companies to assess their Scope 3 emissions and comply with regulatory requirements related to sustainability. Furthermore, it offers tools for conducting Life Cycle Assessments and calculating Product Carbon Footprints, ensuring a reliable record of environmental impact. The MassBalancer solution helps manage materials while adhering to defined processes, enabling efficient generation of sustainability declarations. Central to Circularise’s approach is the patented Smart Questioning feature, which empowers clients to control their data sharing, thereby enhancing privacy and minimizing manual errors in reporting sourcing, carbon footprint, and human rights issues.

Greencovery develops food upcycling technology to recover valuable ingredients from side streams, enabling faster and more sustainable time-to-market for upcycled ingredients. The company's proprietary processes extract natural ingredients that would otherwise be discarded, delivering products with low carbon footprints produced near target markets and maintaining high functionality. Its focus spans savoury flavours, proteins and amino acids, dietary fibres and fruity flavours. Greencovery conducts trials to design the industrial process and required capacity for production and connects companies with food manufacturers to accelerate commercialization. By reclaiming value from discarded raw materials, Greencovery helps reduce waste and environmental impact while expanding the practical use of side-streams in the food industry.

S+dB B.V. specializes in enhancing plant seed technology, focusing on improving seed germination, seedling establishment, and seed handling. Established in 2014 and located in Weert, the Netherlands, the company develops innovative seed-embedding technology that supports optimal growth conditions during critical phases of seed development. Their SET platform technology not only enhances seed vigor and guarantees uniform crop growth with a robust root foundation, but it also offers weed control and protection against environmental stresses. S+dB provides a range of grass seed products suitable for both domestic gardening and professional markets, ensuring that their solutions are scalable and adaptable for various applications.

Niostem is a startup developing a wearable device that harnesses the body's regenerative potential to stimulate hair growth and prevent baldness. This non-invasive solution aims to restore natural hair regeneration without relying on drugs or surgical procedures.

Verdify is a foodtech company that specializes in developing software for personalized online meal inspiration. Its platform allows users to create a fully customized experience by tailoring recipe content to match individual nutrition profiles, dietary preferences, and lifestyle choices. The application enables users to convert traditional recipes into alternative versions, such as plant-based or gluten-free, ensuring that diverse dietary needs are met. Additionally, Verdify's technology integrates recipe advertising, promoting future-focused food brands within the online recipe context. Through its innovative approach, Verdify empowers individuals to make healthier food choices that align with both personal health goals and sustainability considerations.

Neuroplast is a biotechnology company developing a platform to enable autologous stem cell therapies and regenerative medicine. The platform focuses on isolating, manufacturing, and reinserting patients’ own cells to treat spinal cord injuries, amyotrophic lateral sclerosis, and traumatic brain injuries, with the aim of delivering qualified autologous therapies to the global market and supporting physicians in improving patients’ quality of life.

Vertoro develops biobased products from woody and agricultural residues, converting them into a range of bio-based chemicals, materials, and fuels. The company produces crude lignin oil and crude sugar oil from forestry and farm residues, intended as alternatives to fossil resources. These oils can function as liquid raw materials for the petrochemical industry and as platform inputs for materials, chemicals, and fuels, providing a sustainable and universal biofuel source.

Qorium is a biotechnology company that employs cell culturing and tissue engineering technologies to produce premium, real leather. Its sustainable, collagen-based leather aims to minimize environmental impact by being independent of the meat industry and deforestation.

Black Bear Carbon BV specializes in the conversion of waste tires into carbon black and green energy, operating from its base in Nederweert, the Netherlands, since its founding in 2010. The company utilizes a circular economy model, transforming end-of-life tires into sustainable products that serve various industries. Its carbon black, derived from controlled pyrolysis and partial combustion of hydrocarbons, is utilized in applications such as tires, technical rubber products, plastics, paints, and inks. In addition to producing carbon black, Black Bear Carbon generates electricity from its operations, which powers its tire shredding processes and supplies energy to local industries and grids. Through these efforts, the company provides businesses with recyclable carbon compounds, contributing to reduced reliance on oil and lower carbon dioxide emissions.

Neuroplast is a biotechnology company developing a platform to enable autologous stem cell therapies and regenerative medicine. The platform focuses on isolating, manufacturing, and reinserting patients’ own cells to treat spinal cord injuries, amyotrophic lateral sclerosis, and traumatic brain injuries, with the aim of delivering qualified autologous therapies to the global market and supporting physicians in improving patients’ quality of life.

AvL Motion develops autonomous harvesting machines for selective harvesting in agriculture, focusing on asparagus and other crops. The company builds a selective asparagus harvester and related robotics that enable moving and harvesting white asparagus, with applicability to green asparagus and zucchini. Its solutions bring industrial automation to the agricultural sector and the food industry, allowing labor reduction and process optimization for small and medium-sized enterprises. Headquartered in Overloon, the Netherlands, AvL Motion's technology supports labor-intensive harvesting tasks by offering autonomous harvesting applications for horticulture.

Vacis specializes in tissue engineering technology for creating body-own blood vessels. Its platform induces the body to form functional blood vessels, offering novel therapeutic options and reducing complications associated with prosthetic vascular grafts.

Grassa BV specializes in the valorization of plant-based streams through bioraffinage. Based in the Netherlands, Grassa converts grass and vegetable waste into high-quality, protein-rich animal feed and other valuable products using its mobile bio-refinery technology. This process generates four main outputs: fibers, protein, phosphate, and 'wei' (sap). By transforming locally available green residual flows such as grass from meadows, agricultural waste, water plants, or nature grass, Grassa supports sustainable agriculture and helps farmers enhance their income while addressing food scarcity.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.